77
Views
12
CrossRef citations to date
0
Altmetric
Special Topic: Progress in Vaccine Research and Development

Preclinical and Clinical Development of a Multi-Envelope, DNA-Virus-Protein (D-V-P) HIV-1 Vaccine

, , , , , , , , & show all
Pages 49-68 | Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Robert M Paris, Jerome H Kim, Merlin L Robb & Nelson L Michael. (2010) Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1. Expert Review of Vaccines 9:9, pages 1055-1069.
Read now

Articles from other publishers (11)

Maryam Bayat, Yahya Asemani & Sajad Najafi. (2021) Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. International Immunopharmacology 97, pages 107679.
Crossref
Edison Ong, Mei U Wong, Anthony Huffman & Yongqun He. (2020) COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning. Frontiers in Immunology 11.
Crossref
Julia L. HurwitzMattia Bonsignori. (2018) Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome. Viral Immunology 31:2, pages 124-132.
Crossref
Juliana de Souza Apostólico, Silvia Beatriz Boscardin, Márcio Massao Yamamoto, Jethe Nunes de Oliveira-Filho, Jorge Kalil, Edecio Cunha-Neto & Daniela Santoro Rosa. (2016) HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost. PLOS ONE 11:1, pages e0145637.
Crossref
Robert E. SealyBart G. JonesSherri L. SurmanKristen BranumNanna M. HowlettPatricia M. FlynnJulia L. Hurwitz. (2016) Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins. Viral Immunology 29:1, pages 64-70.
Crossref
CunXia Liu, ShouWen Du, Chang Li, YuHang Wang, MaoPeng Wang, Yi Li, RongLan Yin, Xiao Li, DaYong Ren, YanQing Qin, JingQiang Ren & NingYi Jin. (2013) Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization. Science China Life Sciences 56:6, pages 531-540.
Crossref
Bart G. Jones, Robert E. Sealy, Xiaoyan Zhan, Pamela J. Freiden, Sherri L. Surman, James L. Blanchard & Julia L. Hurwitz. (2012) UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV. Vaccine 30:21, pages 3188-3195.
Crossref
Jian Ma, Nan Shi, Cheng-Gang Jiang, Yue-Zhi Lin, Xue-Feng Wang, Shuai Wang, Xiao-Ling Lv, Li-Ping Zhao, Yi-Ming Shao, Xian-Gang Kong, Jian-Hua Zhou & Rong-Xian Shen. (2011) A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity. Virology 410:1, pages 96-106.
Crossref
Alexander D. Douglas, Simone C. de Cassan, Matthew D.J. Dicks, Sarah C. Gilbert, Adrian V.S. Hill & Simon J. Draper. (2010) Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. Vaccine 28:44, pages 7167-7178.
Crossref
Scott A. Brown, Sherri L. Surman, Robert Sealy, Bart G. Jones, Karen S. Slobod, Kristen Branum, Timothy D. Lockey, Nanna Howlett, Pamela Freiden, Patricia Flynn & Julia L. Hurwitz. (2010) Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials. Viruses 2:2, pages 435-467.
Crossref
Larissa Herkenhoff Haut & Hildegund C J Ertl. (2009) Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. Journal of Leukocyte Biology 86:4, pages 779-793.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.